Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
Integer Holdings (NYSE:ITGR), a medical device contract development and manufacturing organization, has announced that holders of its 2.125% Convertible Senior Notes due 2028 can now convert their notes into cash and/or shares during the period from July 1 to September 30, 2025.
The conversion option was triggered because ITGR's stock price exceeded 130% of the conversion price for at least 20 trading days within a 30-day trading period ending June 30, 2025. The notes are convertible at a rate of 11.4681 shares per $1,000 principal amount, equivalent to a conversion price of $87.20 per share.
Integer Holdings (NYSE:ITGR), un'organizzazione specializzata nello sviluppo e produzione su contratto di dispositivi medici, ha annunciato che i detentori delle sue Obbligazioni Convertibili Senior al 2,125% con scadenza 2028 possono ora convertire le loro obbligazioni in contanti e/o azioni nel periodo compreso tra il 1° luglio e il 30 settembre 2025.
L'opzione di conversione è stata attivata perché il prezzo delle azioni ITGR ha superato il 130% del prezzo di conversione per almeno 20 giorni di negoziazione all'interno di un periodo di 30 giorni di contrattazione terminato il 30 giugno 2025. Le obbligazioni sono convertibili al tasso di 11,4681 azioni per ogni 1.000 dollari di valore nominale, corrispondente a un prezzo di conversione di 87,20 dollari per azione.
Integer Holdings (NYSE:ITGR), una organización dedicada al desarrollo y fabricación contratada de dispositivos médicos, ha anunciado que los tenedores de sus Notas Convertibles Senior al 2.125% con vencimiento en 2028 ahora pueden convertir sus notas en efectivo y/o acciones durante el período del 1 de julio al 30 de septiembre de 2025.
La opción de conversión se activó porque el precio de las acciones de ITGR superó el 130% del precio de conversión durante al menos 20 días hábiles dentro de un periodo de 30 días de negociación que finalizó el 30 de junio de 2025. Las notas son convertibles a una tasa de 11.4681 acciones por cada 1,000 dólares de valor nominal, lo que equivale a un precio de conversión de 87.20 dólares por acción.
Integer Holdings (NYSE:ITGR)는 의료기기 계약 개발 및 제조 전문 기업으로, 2028년 만기 2.125% 전환사채 보유자들이 2025년 7월 1일부터 9월 30일까지 해당 사채를 현금 및/또는 주식으로 전환할 수 있다고 발표했습니다.
전환 옵션은 ITGR 주가가 2025년 6월 30일 종료된 30거래일 기간 내 최소 20거래일 동안 전환 가격의 130%를 초과했기 때문에 발동되었습니다. 사채는 $1,000 원금당 11.4681주로 전환되며, 이는 주당 $87.20의 전환 가격에 해당합니다.
Integer Holdings (NYSE:ITGR), une organisation spécialisée dans le développement et la fabrication sous contrat de dispositifs médicaux, a annoncé que les détenteurs de ses obligations convertibles senior à 2,125 % échéance 2028 peuvent désormais convertir leurs obligations en espèces et/ou en actions durant la période du 1er juillet au 30 septembre 2025.
Cette option de conversion a été déclenchée car le cours de l'action ITGR a dépassé 130% du prix de conversion pendant au moins 20 jours de bourse sur une période de 30 jours se terminant le 30 juin 2025. Les obligations sont convertibles au taux de 11,4681 actions pour 1 000 dollars de principal, soit un prix de conversion de 87,20 dollars par action.
Integer Holdings (NYSE:ITGR), ein Unternehmen für die Entwicklung und Herstellung von Medizinprodukten im Auftrag, hat bekannt gegeben, dass Inhaber seiner 2,125% Wandelanleihen mit Fälligkeit 2028 ihre Anleihen nun im Zeitraum vom 1. Juli bis 30. September 2025 in Bargeld und/oder Aktien umwandeln können.
Die Umwandlungsoption wurde ausgelöst, weil der Aktienkurs von ITGR mindestens 20 Handelstage innerhalb eines 30-Tage-Handelszeitraums bis zum 30. Juni 2025 über 130% des Wandlungspreises lag. Die Anleihen sind wandelbar zu einem Satz von 11,4681 Aktien pro 1.000 US-Dollar Nennwert, was einem Wandlungspreis von 87,20 US-Dollar pro Aktie entspricht.
- Notes can be converted into cash up to principal amount plus additional cash/shares
- Stock price performance triggered conversion option by exceeding 130% threshold
- Flexibility in settlement method benefits company's cash management
- Potential dilution if company elects to settle conversion with shares
- Conversion could impact company's cash position if settled in cash
Insights
Integer's convertible notes are now eligible for conversion due to strong stock performance, potentially diluting shares but reflecting positive momentum.
Integer Holdings has announced that holders of its
The conversion terms are significant: noteholders can convert at a rate of 11.4681 shares per
This development has several important implications. First, it signals strong market confidence in Integer's performance as a medical device contract manufacturer, as the stock price has sustained levels well above the conversion threshold. Second, if significant conversions occur, it could lead to dilution of existing shareholders, though the cash settlement of principal helps mitigate this effect. Third, early conversions could help Integer reduce its interest expense on the notes, though potentially at the cost of issuing new shares.
The triggering of this conversion option is a technical event arising from stock price performance rather than a strategic decision by management, and Integer has appropriately maintained neutrality by stating they are making no recommendations to noteholders regarding whether to exercise the conversion option.
PLANO, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its
The Notes became convertible because the last reported sale price of shares of the Company’s common stock, for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the calendar quarter ended June 30, 2025, was greater than
The Notes are convertible at a conversion rate of 11.4681 shares of common stock per
The Company has issued a notice to holders with respect to the Conversion Option specifying the applicable terms, conditions and procedures. The notice is available through The Depository Trust Company or by requesting a copy from Wilmington Trust, National Association, which is serving as the conversion agent, at:
Wilmington Trust, National Association
1310 Silas Deane Highway
Wethersfield, CT 06109
Attn: Integer Holdings Corporation Notes Administrator
None of the Company, its Board of Directors or its employees has made or is making any representation or recommendation to any holder as to whether to exercise or refrain from exercising the Conversion Option.
This press release is not an offer to sell, nor a solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which the offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
| Investor Relations: | Media Relations: |
| Kristen Stewart | Kelly Butler |
| kristen.stewart@integer.net | kelly.butler@integer.net |
| 551.337.3973 | 469.731.6617 |
FAQ
What is the conversion rate for Integer Holdings' (ITGR) 2028 convertible notes?
When can holders convert Integer Holdings' (ITGR) 2028 convertible notes?
Why did Integer Holdings' (ITGR) convertible notes become convertible?
How will Integer Holdings (ITGR) settle the convertible notes conversion?
